Immunity to haemophilus influenzae type b after reimmunization with oligosaccharide CRM197 conjugate vaccine in children with human immunodeficiency virus infection

Pediatric Infectious Disease Journal

Volumn 16, Issue 7, 1997, Pages 711-713

  Peters, Vicki B ^a   Sood, Sunil K ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Anticapsular antibody; Haemophilus influenze type b oligosaccharide CRM197 conjugate vaccine; Human immunodeficiency virus infected children

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ADOLESCENT; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; DOSE RESPONSE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HIV INFECTIONS; HUMANS; IMMUNIZATION; OLIGOSACCHARIDES; VACCINES, CONJUGATE;

EID: 0030820777     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199707000-00015     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention. Final 1995 reports of notifiable diseases. MMWR 1996;45:742-54.
2. Peters VB, Sood SK. Immunity to Haemophilus influenzae type b polysaccharide capsule in children with human immunodeficiency virus infection immunized with a single dose of a Haemophilus vaccine. J Pediatr 1994;125:74-7.
3. Sood SK, Schreiber JR, Siber GR, Daum RS. Postvaccination susceptibility to invasive Haemophilus influenzae type b disease in infant rats. J Pediatr 1988;113:814-9.
4. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children under 13 years of age. MMWR 1994; 43(RR-12):1-10.
5. Berkowitz CD, Ward JI, Chung EC, et al. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age. Pediatrics 1990;85: 288-93.
6. Claesson BA, Schneerson R, Trollfors B, Lagergard T, Taranger J, Robbins JB. Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18-to 23-month-old children. J Pediatr 1990;116:929-31.
7. 197 conjugate vaccine. J Pediatr 1991;119:655-7.
8. Gibb D, Giacomelli A, Masters J, et al. Persistence of antibody response to Haemophilus influenzae type b conjugate vaccine in children with vertically acquired HIV infection. Pediatr Infect Dis J 1996;15:1097-101.
9. 197 conjugate vaccine in infants with human immunodeficiency virus infection. J Pediatr 1996;128:363-5.
10. Baker PJ. T cell regulation of the antibody response to bacterial polysaccharide antigens: an examination of some general characteristics and their implications. J Infect Dis 1992;165(Suppl 1):S44-8.
11. Jackson CR, Vavro CL, Valentine ME, et al. Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus. Pediatr Infect Dis J 1997;16:200-4.
12. Ramillo O, Hicks PJ, Borvak J, et al. T cell activation and human immunodeficiency virus replication after influenza immunization of infected children. Pediatr Infect Dis J 1996; 15:197-203.
13. Stanley SK, Ostrowski MA, Justement JS, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996;334:1222-30.
14. Peters VB, Dorante G, Hodes G, Sood S. Antibody response to a booster dose of Haemophilus influenzae type b after reimmunization with oligosaccharide CRM197 conjugate vaccine in HIV-infected children [Abstract I149]. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 17 to 20, 1995.